Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Cyprus

Coordination and Support Action · Running

BRAINN Brain Research and Integrative Neuroscience Network for Covid-19

Coordinator
University of Cyprus, Cyprus
Runs
1 January 2023 to 30 June 2026
Status
Running
EU funding
€1.1m
Total cost
€1.1m
Partners
4 organisations in 4 countries
Type
Coordination and Support Action
Grant agreement
101079001

What the project is doing

In the project's own words, from its summary on CORDIS.

The Brain Research and Integrative Neuroscience Network for COVID-19 (BRAINN) will advance the research and innovation capacity of the University of Cyprus (UCY) as indicated in the ‘Widening Participation & Strengthening the ERA’ Work Programme, by twinning with three advanced partners in brain research, Maastricht University (UM), King’s College London (KCL), and Ghent University (UGent). Through networking activities, training and coordinated actions, BRAINN will develop an innovative applied neuroscience approach to characterise the effects of COVID-19 on brain health and to elevate the standards of assessment, diagnosis, prognosis and treatment of patients with mental health and cognitive problems due to COVID-19.

The UM, KCL and UGent teams have complementary world-renowned expertise in neuroimaging, non-invasive neurostimulation and digitalised assessment methods, extensive research management experience and active interest in post-COVID research. Engaging these teams as partners will provide the required mentoring and training towards a focused and systematic approach to neuroscience research in a mutually beneficial manner to raise the research profile of UCY, as well as strengthen the research management and administrative skills of UCY staff.

BRAINN will benefit all partners, as the standardisation of assessment and treatment protocols will expedite data collection and will safeguard the sustainability and future expansion of the network. Through interdisciplinary research and development of novel methods and technologies, BRAINN will contribute to personalised treatments, bringing both UCY and Cyprus to the scientific forefront. Additionally, BRAINN will address the brain drain challenge that has increased in Cyprus over the recent years and contribute to the reduction in the burden created by COVID-19.

The knowledge and methodologies produced will extend beyond BRAINN, since they will be applicable to other conditions affecting brain health, even when COVID-19 is eradicated.

Topics

Who is involved

OrganisationCityCountryRole
University of CyprusNicosiaCyprusCoordinator
Universiteit GentGentBelgiumParticipant
Universiteit MaastrichtMaastrichtNetherlandsParticipant
King's College LondonLondonUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI